insights_auto
Bakit bumaba ang AGIO 3.77%?
Tingnan ang Higit pang Detalyechevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$32.90
arrow_downward
-3.77%(-1.29) 1D
$32.90
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Set 24, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AGIO...
Buksan
$34.02
Mataas
$34.12
Mababa
$31.37
Mkt. cap
1.96B
Avg. na dami
919.29K
Dami
1.64M
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Buksan
$34.02
Mataas
$34.12
Mababa
$31.37
Mkt. cap
1.96B
Avg. na dami
919.29K
Dami
1.64M
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tungkol sa Agios Pharmaceuticals Inc